Literature DB >> 17268820

Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level.

Mee Y Bartee1, Svetlana Lutsenko.   

Abstract

Copper-transporting ATPase ATP7B (Wilson disease protein) is a member of the P-type ATPase family with characteristic domain structure and distinct ATP-binding site. ATP7B plays a central role in the regulation of copper homeostasis in the liver by delivering copper to the secretory pathway and mediating export of excess copper into the bile. The dual function of ATP7B in hepatocytes is coupled with copper-dependent intracellular relocalization of the transporter. The final destination of ATP7B in hepatocytes during the copper-induced trafficking process is still under debate. We show the results of immunocytochemistry experiments in polarized HepG2 cells that support the model in which elevated copper induces trafficking of ATP7B to sub-apical vesicles, and transiently to the canalicular membrane. In Atp7b-/- mice, an animal model of Wilson disease, both copper delivery to the trans-Golgi network and copper export into the bile are disrupted despite large accumulation of copper in the cytosol. We review the biochemical and physiological changes associated with Atp7b inactivation in mouse liver and discuss the pleiotropic consequences of the common Wilson disease mutation, His1069Gln.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17268820     DOI: 10.1007/s10534-006-9074-3

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  30 in total

1.  Role of hepatocyte nuclear factor 4α in controlling copper-responsive transcription.

Authors:  Min Ok Song; Jonathan H Freedman
Journal:  Biochim Biophys Acta       Date:  2010-09-27

Review 2.  Cellular multitasking: the dual role of human Cu-ATPases in cofactor delivery and intracellular copper balance.

Authors:  Svetlana Lutsenko; Arnab Gupta; Jason L Burkhead; Vesna Zuzel
Journal:  Arch Biochem Biophys       Date:  2008-05-21       Impact factor: 4.013

3.  Identification of one novel and nine recurrent mutations of the ATP7B gene in 11 children with Wilson disease.

Authors:  Juan Geng; Jian Wang; Ru-En Yao; Xiao-Qing Liu; Qi-Hua Fu
Journal:  World J Pediatr       Date:  2012-12-29       Impact factor: 2.764

4.  ATP7B detoxifies silver in ciliated airway epithelial cells.

Authors:  Aida Ibricevic; Steven L Brody; Wiley J Youngs; Carolyn L Cannon
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-11       Impact factor: 4.219

5.  Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.

Authors:  Karoline Leonhardt; Rolf Gebhardt; Joachim Mössner; Svetlana Lutsenko; Dominik Huster
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

6.  NMR structural analysis of the soluble domain of ZiaA-ATPase and the basis of selective interactions with copper metallochaperone Atx1.

Authors:  Lucia Banci; Ivano Bertini; Simone Ciofi-Baffoni; Luisa Poggi; Murugendra Vanarotti; Stephen Tottey; Kevin J Waldron; Nigel J Robinson
Journal:  J Biol Inorg Chem       Date:  2009-07-16       Impact factor: 3.358

7.  Multiple metal binding domains enhance the Zn(II) selectivity of the divalent metal ion transporter AztA.

Authors:  Tong Liu; Hermes Reyes-Caballero; Chenxi Li; Robert A Scott; David P Giedroc
Journal:  Biochemistry       Date:  2007-09-08       Impact factor: 3.162

8.  The loop connecting metal-binding domains 3 and 4 of ATP7B is a target of a kinase-mediated phosphorylation.

Authors:  Mee Y Bartee; Martina Ralle; Svetlana Lutsenko
Journal:  Biochemistry       Date:  2009-06-23       Impact factor: 3.162

Review 9.  Copper-transporting ATPases ATP7A and ATP7B: cousins, not twins.

Authors:  Rachel Linz; Svetlana Lutsenko
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

Review 10.  Biochemical basis of regulation of human copper-transporting ATPases.

Authors:  Svetlana Lutsenko; Erik S LeShane; Ujwal Shinde
Journal:  Arch Biochem Biophys       Date:  2007-05-02       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.